EVA; A novel therapeutic targeting Rationale for the Treatment of Glioblastoma.

被引：0
|
作者：
Rusch, Tillmann [1 ]
Zhao, Kai [2 ]
Neubauer, Andreas [1 ]
Nimsky, Christopher [2 ]
Bartsch, Joerg [2 ]
机构：
[1] UKGM Giessen & Marburg, Standort Marburg, Klin Hamatol Onkol & Immunol, Marburg, Germany
[2] UKGM Giessen & Marburg, Standort Marburg, Klin Neurochirurgie, Marburg, Germany
来源：
INNERE MEDIZIN | 2024年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P16-10
引用
收藏
页码：S113 / S113
页数：1
相关论文
共 50 条
  • [1] Therapeutic targeting of VEGF in the treatment of glioblastoma
    Irizarry, Lizbeth Robles
    Hambardzumyan, Dolores
    Nakano, Ichiro
    Gladson, Candece L.
    Ahluwalia, Manmeet S.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2012, 16 (10) : 973 - 984
  • [2] The Rationale of Targeting Neutrophils with Dapsone during Glioblastoma Treatment
    Kast, Richard E.
    Scheuerle, Angelika
    Wirtz, Christian R.
    Karpel-Massler, Georg
    Halatsch, Marc-Eric
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2011, 11 (08) : 756 - 761
  • [3] Targeting PIK3CB in glioblastoma.
    Fromherz, Marc R.
    Pridham, Kevin J.
    Sheng, Zhi
    CANCER RESEARCH, 2022, 82 (12)
  • [4] A phase Ib/II clinical trial of a novel oxygen therapeutic in chemoradiation of glioblastoma.
    Unger, Evan C.
    Lickliter, Jason D.
    Ruben, Jeremy
    Jennens, Ross
    Kichenadasse, Ganessan
    Gzell, Cecelia
    Mason, Ralph
    Carmody, Raymond
    Becker, Jennifer
    Zhou, Heling
    Sellenger, Michael
    Longacre, Olivia
    Graham, Kaitlin
    Stea, Baldassarre
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [5] Targeting of HOX-PBX binding in glioblastoma multiforme as a novel therapeutic treatment
    Morgan, Richard
    Primon, Monika
    Shnyder, Steven
    Short, Susan
    Kaur, Balveen
    Hong, Bangxing
    Bagwan, Izhar
    Rogers, William
    Pandha, Hardev S.
    CANCER RESEARCH, 2019, 79 (13)
  • [6] A NEUROENDOCRINE APPROACH IN THE TREATMENT OF BRAIN GLIOBLASTOMA.
    Porta, E.
    Messina, G.
    Porro, G.
    Lissoni, P.
    ANTICANCER RESEARCH, 2014, 34 (10) : 6118 - 6118
  • [7] Engagement of cellular prion and heat shock organizing protein as a novel therapeutic target for glioblastoma.
    Lopes, M. H.
    Queiroz-Hazarbassanov, N. T.
    Rodrigues, B. R.
    Santos, T. G.
    Cunha, I. W.
    Oba-Shinjo, M.
    Marie, S. K.
    Martins, V. R.
    MOLECULAR BIOLOGY OF THE CELL, 2012, 23
  • [8] Role of intratumoral cell heterogeneity on therapeutic efficacy in glioblastoma.
    Chakravarty, Debyani
    Pedraza, Alicia
    Liu, Angela H.
    Cotari, Jesse
    Altan-Bonnet, Gregoire
    Brennan, Cameron W.
    CANCER RESEARCH, 2013, 73 (08)
  • [9] Tumor targeting peptides: novel therapeutic strategies in glioblastoma
    Raucher, Drazen
    CURRENT OPINION IN PHARMACOLOGY, 2019, 47 : 14 - 19
  • [10] Effect of therapeutic pressure on stability of EGFR amplification in glioblastoma.
    Ahluwalia, Manmeet Singh
    Dimino, Cara R.
    Mansukhani, Mahesh M.
    Murty, Vundavalli V.
    Canoll, Peter
    Narita, Yoshitaka
    Muragaki, Yoshihiro
    Gan, Hui Kong
    Merrell, Ryan Thomas
    Van den Bent, Martin J.
    Zha, Zheng
    Roberts-Rapp, Lisa
    Jiang, Fang
    Guseva, Maria
    Bain, Earle E.
    Ocampo, Christopher Joseph
    Ansell, Peter J.
    Lassman, Andrew B.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345